# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Immune Thrombocytopenic Purpura

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 56 results.
A Study of PRN1008 in Adult Patients With Immune Thrombocytopenic Purpura (ITP)
Status: Recruiting
Last Changed: Jan 30, 2019
First Received: Jan 10, 2018
Disease(s): Immune Thrombocytopenic Purpura
Intervention(s): PRN1008
Locations: Central Recruiting (Principia Biopharma), Peoria, Illinois, United States
Central Recruiting (Principia Biopharma), Bethesda, Maryland, United States
Central Recruiting (Principia Biopharma), Boston, Massachusetts, United States
Central Recruiting (Principia Biopharma), Midland, Michigan, United States
Central Recruiting by Principia Biopharma, New York, New York, United States
... and 12 other locations.
Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients
Status: Recruiting
Last Changed: Jul 18, 2019
First Received: Mar 07, 2019
Disease(s): Immune Thrombocytopenic Purpura (ITP)
Intervention(s): Biological: M254, Placebo, Intravenous immunoglobulin (IVIg)
Locations: Momenta Investigational Site, Los Angeles, California, United States
Momenta Investigational Site, Saint Petersburg, Florida, United States
Momenta Investigational Site, Durham, North Carolina, United States
Momenta Investigational Site, Cleveland, Ohio, United States
Momenta Investigational Site, Yvoir, Namur, Belgium
... and 19 other locations.
Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura
Status: Not yet recruiting
Last Changed: Feb 01, 2018
First Received: Jun 01, 2017
Disease(s): Immune Thrombocytopenia
Intervention(s): Amoxicillin 50 mg/kg/day in 2 divided doses for 14 days., Clarithromycin 15 mg/kg/day in 2 divided doses for 14 days., Proton pump inhibitor 1 mg/kg/day in 2 divided doses 1 month
H. Pylori Eradication for Moderate ITP
Status: Recruiting
Last Changed: Sep 07, 2018
First Received: Jun 06, 2017
Disease(s): Immune Thrombocytopenic Purpura, Helicobacter Pylori, Immune Thrombocytopenia
Intervention(s): treatment : H. pylori eradication
Locations: Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children
Status: Recruiting
Last Changed: May 09, 2019
First Received: May 07, 2019
Disease(s): Immune Thrombocytopenia
Intervention(s): Eltrombopag, Steroids, IVIG, Rho(D) Immune Globulin
Locations: UCSF Benioff Children's Hospital, San Francisco, California, United States
Boston Children's Hospital, Boston, Massachusetts, United States
Texas Children's Hospital, Houston, Texas, United States
Evaluation of HRQoL in Adult With Immune Thrombocytopenia in China
Status: Recruiting
Last Changed: Oct 27, 2017
First Received: Oct 27, 2017
Disease(s): Immune Thrombocytopenia
Intervention(s): HRQoL
Locations: Shandong University Qilu hospital, Jinan, Shandong, China
Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia
Status: Recruiting
Last Changed: Oct 23, 2018
First Received: Nov 21, 2014
Disease(s): Immune Thrombocytopenia
Intervention(s): Eltrombopag, Romiplostin
Locations: S.O.C. di Medicina Interna B - Ospedale - Cardinal Massaia di Asti, Asti, Italy
Istituto di Ematologia "Lorenzo e A. Seragnoli", Bologna, Italy
Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi, Catania, Italy
Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano, Firenze, Italy
Clinica Medica III - Padiglione ex isolamento - Azienda Ospedale Università San Martino, Genova, Italy
... and 9 other locations.
Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura
Status: Recruiting
Last Changed: Feb 05, 2019
First Received: Feb 05, 2019
Disease(s): Immune Thrombocytopenia
Intervention(s): Eltrombopag
Locations: Humanity & Health Research Centre, Hong Kong, Hong Kong SAR, Hong Kong
Risk Factors for Thrombosis in Immune Thrombocytopenia
Status: Recruiting
Last Changed: Apr 26, 2019
First Received: Jan 29, 2019
Disease(s): Immune Thrombocytopenia
Locations: University Hospital Toulouse, Toulouse, France
Immune Thrombocytopenia in Pregnancy
Status: Recruiting
Last Changed: Oct 19, 2017
First Received: Sep 08, 2016
Disease(s): Immune Thrombocytopenia, Pregnancy
Intervention(s): No intervention
Locations: Henri Mondor Hospital, Creteil, France